Sudler's Amy Duda to present at Cannes Lions Health Festival
8 June, 2015
— Sudler & Hennessey, one of the leading global healthcare communication networks, is pleased to announce that Amy Duda, EVP, Director of Strategic Planning and Market Analytics at Sudler New York, will be speaking at the Cannes Lions Healthcare Festival, in the Debussy Theater, 12:45pm, on June 19, 2015.
Amy will be joined by Jonathan Richman, founder of DOSE, to discuss “Lies, Damned Lies & Statistics” — examining how data and statistics are relevant in healthcare campaigns as more patients turn inward towards their quantified selves with health apps and wearable technology. Participants are invited to put their statistical hopes and fears under analysis!
With a strong background in genomics and clinical research, Amy creates new ideas, formulates insight-driven strategies. Her experience and expertise include a focus on oncology, with an emphasis on both US and global launches, clinical trial and population genomics, and data analysis and drug target identification with the European Institute of Oncology, Yale University School of Medicine and Genaissance Pharmaceuticals.
For more information, contact:
Cathy.Robins@sudler.com (+1 212-614-3818)
About Sudler & Hennessey
The S&H Group is a global healthcare marketing and communications organization with offices around the world. The network includes two global communications agencies, Sudler & Hennessey and Sentrix Global Health Communications, with US headquarters in New York City. S&H also has specialized divisions in medical education (IntraMed Educational Group, Precept Medical Communications, and CMDNY), as well as in market research and strategic planning, branding, publication strategies, sales training (HealthAnswers and Transart), digital solutions (Sudler Digital), eHealth Solutions (Sudler eHealth Group), consulting (Primary Source), healthcare management (Quality Matters), and consumer health marketing (Sudler Consumer). For more information, please visit www.sudler.com
S&H is part of Young and Rubicam Group, and part of WPP (NASDAQ: WPPGY; www.wpp.com)